Scientific poster download
High-throughput RT-qPCR for small molecule screening assays in advanced cellular models
Pharmaceutical development is risky. It can take $1 billion and 12.5 years to launch a technically successful drug. To increase effectiveness of drug discovery, new disease-relevant cellular models have been developed. Quantitative reverse transcription PCR (RT-qPCR) represents a method of choice to perform gene
expression assays in the most disease-relevant cellular models.
Evotec HTS RT-qPCR platform has been designed to perform screening campaigns in the most advanced cellular models.
Recently presented by our High Throughput Biology and Screening expert, Romain Chassefeyre, at SLAS Europe 2019, download your copy of our scientific poster here and discover more!